// App-Quantinova.ai

3117 : Impact of Myeloablative and Reduced Intensity Conditioning On Outcomes After Unrelated Cord Blood Transplantation for Adults with Acute Lymphoblastic Leukemia.

Researchers

Presenter

  • Annalisa Ruggeri

Principal Investigators

  • Guillermo Sanz

  • Pau Montesinos

  • Duncan Purtill

  • Eliane Gluckman

  • Vanderson Rocha

  • Sabine Furst

  • Bernard Rio

  • Gerard Socie

  • William Arcese

  • Mauricette Michallet

  • Ibrahim Yakoub-Agha

  • Jan J Cornelissen

  • Miguel Angel Sanz

Medical Centers

  • Chru, CHU de Lille, Lille, France

  • Clinical Hematology, Hospital U. La Fe, Valencia, Spain

  • Hematology, Hospital Universitario La Fe, Valencia, Spain

  • Hematology, Edouard Herriot Hospital, Lyon, France

  • Eurocord International Registry, Hopital Saint-Louis, Paris, France

  • Hematology, Erasmus MC/Daniel Den Hoed, Rotterdam, Netherlands

  • Eurocord International Registry, Paris, France

  • Hematology and Bone Marrow Transplantation, Saint-Louis Hospital, Paris, France,

  • hematology, Hotel-Dieu Assistance Publique-Hopitaux de Paris APHP, Paris, France

  • Hematology Division - Stem Cell Transplant Unit, University of Rome Tor Vergata,

  • HEMATOLOGY, Institut Paoli Calmettes, marseille, France

  • Servicio Oncologia Medica Hospital Universitario La Fe, Valencia, Spain

Locations

  • France

  • Spain

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

Drug/Treatment

  • thiocoraline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved